Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma

Clinical Biochemistry

Volumn 43, Issue 7-8, 2010, Pages 650-654

  Erdamar, Hüsamettin ^a   Çimen, Behzat ^b   Gülcemal, Harun ^a   Saraymen, Recep ^b   Yerer, Betül ^b   Demirci, Hüseyin ^c  

^a Tunceli Government Hospital   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

^c Department of Endocrinology   (Turkey)

Author keywords

Antioxidants; Lipid peroxidation; Nodular goiter; Papillary carcinomas; Tissue

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PROPYLTHIOURACIL; SELENIUM; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; THYROID GLAND; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TOXIC GOITER;

ANTIOXIDANTS; CARCINOMA, PAPILLARY; FEMALE; GLUTATHIONE PEROXIDASE; GOITER, NODULAR; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; SELENIUM; SUPEROXIDE DISMUTASE; THYROID NEOPLASMS;

EID: 77951204276     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.02.005     Document Type: Article

References (33)

1. Sundaram V., Hanna A.N., Koneru L., Newman H.A., Falko J.M. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J. Clin. Endocrinol. Metab. 1997, 82:3421-3424.
2. Pereira B., Rosa L.F., Safi D.A., Bechara E.J., Curi R. Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J. Endocrinol. 1994, 140:73-77.
3. Resch U., Helsel G., Tatzber F., Sinzinger H. Antioxidant status in thyroid dysfunction. Clin. Chem. Lab. Med. 2002, 40:1132-1134.
4. 2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinology 1991, 128:779-785.
5. Guerrero A., Pamplona R., Portero-Otin M., Barja G., Lopez-Torres M. Effect of thyroid status on lipid composition and peroxidation in the mouse liver. Free Radic. Biol. Med. 1999, 26:73-80.
6. Nishiki K., Erecinska M., Wilson D.F., Cooper S. Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid, and hyperthyroid rats. Am. J. Physiol. 1978, 235:C212-C219.
7. Chevion M., Berenshtein E., Stadtman E.R. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic. Res. 2000, 33 Suppl:S99-S108.
8. Alexander E.K., Marqusee E., Orcutt J., et al. Thyroid nodule shape and prediction of malignancy. Thyroid 2004, 14:953-958.
9. Mihara M., Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86:271-278.
10. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34:497-500.
11. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
12. Mishra O.P., Delivoria-Papadopoulos M., Wagerle L.C. Anti-oxidant enzymes in the brain of newborn piglets during ischemia followed by reperfusion. Neuroscience 1990, 35:211-215.
13. Zagrodzki P., Nicol F., Arthur J.R., et al. Selenoenzymes, laboratory parameters, and trace elements in different types of thyroid tumor. Biol Trace Elem Res 2009, 10.1007/s12011-009-8454-2.
14. Karakucuk S., Ertugrul Mirza G., Faruk Ekinciler O., Saraymen R., Karakucuk I., Ustdal M. Selenium concentrations in serum, lens and aqueous humour of patients with senile cataract. Acta Ophthalmol. Scand. 1995, 73:329-332.
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
16. Abalovich M., Llesuy S., Gutierrez S., Repetto M. Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments. Clin. Endocrinol. (Oxf.) 2003, 59:321-327.
17. Erdamar H., Demirci H., Yaman H., et al. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin. Chem. Lab. Med. 2008, 46:1004-1010.
18. Komosinska-Vassev K., Olczyk K., Kucharz E.J., Marcisz C., Winsz-Szczotka K., Kotulska A. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin. Chim. Acta 2000, 300:107-117.
19. Nadolnik L.I., Valentyukevich O.I. Peculiarities of the antioxidant status of the thyroid gland. Bull. Exp. Biol. Med. 2007, 144:529-531.
20. Dupuy C., Virion A., Ohayon R., Kaniewski J., Deme D., Pommier J. Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid plasma membrane. J. Biol. Chem. 1991, 266:3739-3743.
21. Ademoglu E., Ozbey N., Erbil Y., et al. Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease. Eur. J. Intern. Med. 2006, 17:545-550.
22. Arthur J.R. The role of selenium in thyroid hormone metabolism. Can. J. Physiol. Pharmacol. 1991, 69:1648-1652.
23. Dickson R.C., Tomlinson R.H. Selenium in blood and human tissues. Clin. Chim. Acta 1967, 16:311-321.
24. Behne D., Hilmert H., Scheid S., Gessner H., Elger W. Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim. Biophys. Acta 1988, 966:12-21.
25. Gartner R., Gasnier B.C., Dietrich J.W., Krebs B., Angstwurm M.W. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab. 2002, 87:1687-1691.
26. Durak I., Bayram F., Kavutcu M., Canbolat O., Ozturk H.S. Impaired enzymatic antioxidant defense mechanism in cancerous human thyroid tissues. J. Endocrinol. Invest. 1996, 19:312-315.
27. Nadol'nik L.I., Grivachevskii A.S., Petushok N.E., Khomich T.I., Vinogradov V.V. [Antioxidant system activities and lipid peroxidation in nodal and non-nodal thyroid tissue of patients operated in connection with euthyroid nodular goiter]. Biomed. Khim. 2006, 52:403-412.
28. Rom-Boguslavskaia E.S., Somova E.V., Ovsiannikova T.N., Diageleva E.A., Karachentsev Iu I., Asaula V.A. Lipid peroxidation in thyroid tissue of people with diffuse toxic goiter. Ukr. Biokhim. Z. 1997, 69:111-114.
29. Sadani G.R., Nadkarni G.D. Role of tissue antioxidant defence in thyroid cancers. Cancer Lett. 1996, 109:231-235.
30. Mano T., Shinohara R., Iwase K., et al. Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm. Metab. Res. 1997, 29:351-354.
31. Bacic-Vrca V., Skreb F., Cepelak I., Mayer L., Kusic Z., Petres B. The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease. Clin. Chem. Lab. Med. 2005, 43:383-388.
32. Vrca V.B., Skreb F., Cepelak I., Romic Z., Mayer L. Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium. Clin. Chim. Acta 2004, 341:55-63.
33. Oster O., Schmiedel G., Prellwitz W. Correlations of blood selenium with hematological parameters in West German adults. Biol. Trace Elem. Res. 1988, 15:47-81.